Europe · Exchanges & live quotes · Euronext
EQT to buy molecular testing firm Qiagen for $10.8 billion
Oct 21 (Reuters) - Sweden's EQT will buy molecular testing company Qiagen for about €9.6 billion ($10.78 billion), the companies said on Wednesday, ending years of takeover…
Read the full article on Euronext Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (live.euronext.com)
